Navigation Links
Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results
Date:3/13/2009

al expenses in connection with the commercialization of Intermezzo(R); Transcept product candidates may have unexpected adverse side effects or inadequate therapeutic efficacy; positive results in clinical trials may not be sufficient to obtain FDA approval; physician or patient reluctance to use Intermezzo(R), if approved; potential alternative therapies; maintaining adequate patent or trade secret protection without violating the intellectual property rights of others; and other difficulties or delays in, clinical development, obtaining regulatory approval, market acceptance and commercialization of Transcept product candidates.

    Contacts:

    Transcept Pharmaceuticals, Inc.        The Ruth Group
    Michael Gill                           Investors / Media
    Director of Communications             Stephanie Carrington / Jason Rando
    (510) 215-3575                         (646) 536-7017 / 7025
    mgill@transcept.com                    scarrington@theruthgroup.com
                                           jrando@theruthgroup.com



'/>"/>
SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
2. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
3. Transcept Pharmaceuticals to Present at 19th Annual Piper Jaffray Health Care Conference
4. Transcept Pharmaceuticals to Present at RBC Capital Markets 2007 Healthcare Conference
5. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
7. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
8. Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston
9. Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
10. Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
11. Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put ... muscle by up to 30lbs in less than 12 weeks ... Stan Stevenson, prompting an investigative review. , “Our Incredible ... diet formula that allows the body to pack on a ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue ... means to “Live Fearless.” , The “Faces of ... stories about how they or someone they know has faced ... in the moment. By telling these types of stories through ...
(Date:1/22/2015)... 22, 2015 The federal court overseeing thousands ... District Court, Southern District of West Virginia has upheld a ... proceeding’s first bellwether trial. In an Order dated January 21st, ... after finding that C.R. Bard had not proven a miscarriage ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A new ... of experience and person-centeredness in the long-term care environment ... action across the continuum. The paper, “The Power of ... engages perspectives and practices of the patient, resident and ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining ... policy . , Auto insurance quotes help many drivers ... longer necessary to call an agent or visit an agency ... a single website: http://autocarinsurancebest.com/ . , Every business who ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2
... TriCipher will host an,informative Webinar ... the pharmaceutical and health care industries and strategies,for ... online.,The one hour webinar on December 16th brings ... will discuss how digital signatures have,benefited and streamlined ...
... TotalHospital Jobs , , PRINCETON, N.J., ... for the state, providing more than 113,000 full-time jobs, $7 billion ... according to the New Jersey Hospitals 2008 Economic Impact Report. ... been known for their societal contributions, including $1.3 billion in annual ...
... from Electronic Sports, leads the next generation of exergaming fitness products ... , ... Salt Lake City, UT (PRWEB) December 16, ... a full featured flight simulator interfaced with a high-end exercise bike. ...
... DALLAS, Dec. 16 U.S. Preventive Medicine, the leader in ... of former Senate Majority Leader Tom Daschle (D-SD) to head ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20080506/NETU129LOGO ) ... an excellent choice for Secretary of this vitally important agency, ...
... , ROCKVILLE, Md., Dec. 16 Some ... are likely to die in alcohol-related traffic crashes on New Year,s ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20081216/NE52502 ) , ... recent analysis of National Highway Traffic Safety Administration statistics shows that, ...
... American Journal of Clinical Nutrition Reports Almonds, Impact on ... Calif., Dec. 16 The Almond Board of California ... overcome dietary challenges, especially during the holiday season. Resolutions ... be maintained throughout the year, as heart disease takes ...
Cached Medicine News:Health News:Pharmaceutical and Health Care Experts to Detail Cost-Cutting Capabilities of Secure Digital Signatures 2Health News:Pharmaceutical and Health Care Experts to Detail Cost-Cutting Capabilities of Secure Digital Signatures 3Health News:Report: Hospitals Pump $18 Billion Into N.J. Economy 2Health News:Electronic Sports Launches Dogfight Fitness Flight Simulator: The Next Generation of Exergaming 2Health News:Electronic Sports Launches Dogfight Fitness Flight Simulator: The Next Generation of Exergaming 3Health News:U.S. Preventive Medicine Praises Selection of Tom Daschle to Serve as Secretary of Health and Human Services 2Health News:New Year, Old Myths, New Fatalities 2Health News:New Year, Old Myths, New Fatalities 3Health News:Give Your Heart a Holiday: Eating Almonds Helps Support Healthy Fat Levels 2Health News:Give Your Heart a Holiday: Eating Almonds Helps Support Healthy Fat Levels 3Health News:Give Your Heart a Holiday: Eating Almonds Helps Support Healthy Fat Levels 4Health News:Give Your Heart a Holiday: Eating Almonds Helps Support Healthy Fat Levels 5
(Date:1/23/2015)... , Jan. 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: ... immune therapies for operable and inoperable solid tumor cancers, announced ... the 7 th Annual Phacilitate Immunotherapy Forum in ... at Phacilitate will take place on January 26 at 10:30 ...
(Date:1/23/2015)... and DUBLIN , Jan. 23, ... agreement with KRS Global Biotechnology, Inc. for the compounding, packaging ... compounded for shipment in the United States ... approved Outsourcing Facility capable of compounding naltrexone tablets in various ...
(Date:1/23/2015)... Fla. , Jan. 23, 2015  HyGreen, Inc., a ... agreement and partnership with RCA Medical, a subsidiary of ... . Each year, hundreds of millions ... care-associated infections as organisms are transmitted from patient to ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2
... 13, 2011 Life Spine, a medical device company ... surgical treatment of spine disorders, today announced that the ... offerings and technologies at the 6th Annual Spine Technology ... 12th, 2011, in Napa, California. "Life Spine ...
... MedClean Technologies, Inc. (OTC Bulletin Board: ... the treatment and disposal of medical waste and the ... it has formed a co-marketing agreement with Covidien, a ... relationship, Covidien,s national sales force for SharpSafety products will ...
Cached Medicine Technology:MedClean Technologies Forms Co-Promotion Relationship With Covidien, Leading Global Healthcare Products Manufacturer 2MedClean Technologies Forms Co-Promotion Relationship With Covidien, Leading Global Healthcare Products Manufacturer 3
... Acid-labile subunit (ALS) is a GH dependent ... a 578 amino acid peptide with a predicted ... serum are mostly confined to a ~150 KDa ... molecule of IGF-I or IGF-II, and this unique ...
... The Medtronic SelectSecure Lead System (Model ... lead. Its unique, lumenless design allows for ... F) without sacrificing insulation thickness. The SelectSecure ... allow positioning of the lead in select ...
... glucuronide (3alpha-diol G) is the glucuronide ... of dihydrotestosterone (DHT) [1,2]. 3alpha-diol G ... 75% of the bioactivity of testosterone ... product of intracellular reduction of DHT, ...
... are polypeptide hormones which belong to ... The TGF- superfamily is a large ... control many aspects of development, reproductive ... members incude TGF-s, bone morphogenetic proteins, ...
Medicine Products: